The rise of Viagra initially sparked a surge for the drug industry, however recent shifts present a murky outlook for shareholders. Generic versions are reducing earnings, and ongoing legal battles add further https://haimauyrt718344.jiliblog.com/97575890/the-blue-pill-and-pharma-a-precarious-investment